A Study of LY573636-Sodium in the Treatment of Patients With Metastatic Soft Tissue Sarcoma
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The primary purpose of the study is to estimate the time from the first dose of
LY573636-sodium (hereafter referred to as LY573636) to the date your physician determines
that your disease has progressed or worsened.